title: MitraClip Registries: what have we learned recently.
abstract: MitraClip therapy is emerging as an alternative treatment for primary and secondary mitral regurgitation in high risk patients. A randomized trial has shown safety in selected patients, with efficacy non inferior to surgery in elderly patients with functional mitral regurgitation. Following commercialization, MitraClip therapy is offered to patients very different from the profile of those enrolled in the randomized trial. Several registries are on the way and provide useful preliminary information related to real-world experience with percutaneous mitral valve repair with the MitraClip system.
authors.affiliation: Cardiothoracic Department, San Raffaele Hospital, Milan, Italy. francesco.maisano@hsr.it
authors.forename: F
authors.initials: F
authors.lastname: Maisano
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D016330:Frail Elderly; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000503:physiopathology / Q000628:therapy*; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012042:Registries; D012107:Research Design; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome